We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6078:HKEXHygeia Healthcare Holdings Co., Ltd. Analysis

Data as of 2026-07-30 - not real-time

¥1,546.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Value HR Co.,Ltd. is trading near its 20‑day SMA of 1,503, with the price at 1,546, comfortably above the 50‑day SMA but slightly below the 200‑day SMA, indicating a neutral trend. The MACD histogram remains positive (≈2.8) and the signal line is bullish, while the RSI sits at 61.8, suggesting modest upward momentum without being overbought. Volatility over the past 30 days is elevated at roughly 23%, and the beta of 0.07 points to extremely low market‑wide price sensitivity. Valuation metrics are stretched: a trailing P/E of 66× dwarfs the industry average of 30×, and the price‑to‑book of 6.2× further underscores the premium pricing. The dividend yield of 1.73% is modest, but the payout ratio exceeds 110%, raising concerns about dividend sustainability. Overall, the stock shows technical strength but fundamental overvaluation and a weak dividend profile, suggesting caution for investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD and stable volume support near‑term price stability
  • Technical price positioned between support (1,455) and resistance (1,568)
  • Overvalued fundamentals temper upside potential

Medium Term

1–3 years
Cautious
Model confidence: 5/10

Key Factors

  • High P/E relative to industry suggests valuation correction risk
  • Unsustainable dividend payout ratio may lead to dividend cuts
  • Moderate volatility and recent max drawdown of ~28% increase downside risk

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Revenue growth of ~12% indicates underlying business expansion
  • Low beta reflects defensive nature of healthcare services
  • Valuation may normalize over time, offering potential upside if multiple compresses

Key Metrics & Analysis

Financial Health

Revenue Growth12.60%
Profit Margin5.79%
P/E Ratio66.0
ROE9.07%
ROA2.98%
Debt/Equity86.33
P/B Ratio6.2
Industry P/E29.9

Technical Analysis

TrendNeutral
RSI61.8
Support¥1,455.00
Resistance¥1,568.00
MA 20¥1,503.55
MA 50¥1,441.52
MA 200¥1,510.20
MACDBullish
VolumeStable
Fear & Greed Index84.54

Valuation

GradeOvervalued
TypeBlend
Dividend Yield1.73%

Risk Assessment

Beta0.08
Volatility23.27%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.